Cite

HARVARD Citation

    , . et al. (2018). FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial. European journal of cancer. pp. 108-116. [Online]. 
  
Back to record